查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018873

除颤器市场：去心房颤动类型、技术、患者群体、最终用户和供应管道划分－2026-2032年全球市场预测

Defibrillators Market by Type, Technology, Patient Type, End User, Supply Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，去心房颤动市场价值将达到 118.6 亿美元，到 2026 年将成长至 127.9 亿美元，到 2032 年将达到 206.1 亿美元，复合年增长率为 8.20%。

主要市场统计数据
基准年 2025 118.6亿美元
预计年份：2026年 127.9亿美元
预测年份：2032年 206.1亿美元
复合年增长率 (%) 8.20%

对去心房颤动技术的演变和塑造全球心臟麻痹应对未来的市场动态进行全面分析。

近几十年来，全球救生去心房颤动技术格局发生了翻天覆地的变化，这主要得益于持续的创新以及人们对心臟麻痹这一重大公共卫生问题的日益重视。最初，除颤器仅限于医院和专科心臟中心，而如今，现代去心房颤动解决方案已扩展到穿戴式装置、公共自动体外心臟去心房颤动(AED) 和先进的植入式系统。这种扩展不仅反映了波形优化和感测器整合的技术突破，也反映了临床和社区层面预防性心臟保健的更广泛趋势。

本文探讨了重新定义去心房颤动开发的关键驱动因素和技术进步，以改善紧急医疗中的病患预后。

如今的去心房颤动创新是由多种因素共同推动的，这些因素全面重塑了危急时刻的患者照护。双相波形演算法的进步优化了能量输出，提高了去心房颤动成功率，同时减少了心肌损伤。同时，电子元件和电池系统的微型化使得去心房颤动的製造成为可能，这种除颤器能够持续监测心率，并在院外自动实施治疗。除了这些技术突破之外，整合的即时患者数据传输功能也促进了远端监测和及时干预，使临床医生能够更有效地接收和处理患者数据。

评估 2025 年美国关税变化对去心房颤动供应链、定价方法和国际合作的影响。

美国计划于2025年初调整进口关税，促使全球去心房颤动供应链、成本结构和合作伙伴关係重新评估。先前依赖亚洲零件的製造商开始实现供应商多元化，以缓解关税带来的成本上涨。这种策略重组正在加速对本地生产设施的投资，加强与区域契约製造的合作关係，并增强应对未来贸易政策变化的能力。

细分市场分析揭示了去心房颤动类型、技术、患者人口统计特征、使用环境和分销方式如何推动其普及。

对去心房颤动市场细分的详细分析揭示了设备配置、技术特性、患者群体特征、医疗环境和分销管道之间的复杂相互作用。对设备类型分类的检验表明，「体外除颤器」（包括自动体外去心房颤动(AED)、手动体外去心房颤动和可穿戴式去心房颤动系统）与「植入式心臟整流去颤器」（包括双腔、单腔和皮下植入式）之间存在差异。这些区别不仅影响治疗能力，也影响监管要求和临床培训方案。

研究美洲、欧洲、中东、非洲和亚太地区医疗保健生态系统中去心房颤动使用趋势的区域特征。

对区域因素的详细分析揭示了地理差异如何影响去心房颤动的使用模式、监管合规性和投资重点。在美洲，完善的紧急医疗服务网络、广泛的报销机制以及较高的公众意识促成了自动体外心臟去心房颤动（AED）在医疗机构和社区的广泛应用。该地区强大的基础设施，以及先进的培训项目和支援远端监控及事后分析的数位化连接解决方案，使得设备能够快速部署。

主要企业透过策略联盟、技术进步和临床研究伙伴关係，推动去心房颤动创新。

去心房颤动产业的主导集中在少数几家公司手中，这些公司兼具深厚的临床专业知识、大规模研发投入和策略联盟。领先的医疗设备製造商正利用其全球分销网络和监管知识，推广新一代体外和植入式除颤系统。这些公司正与专业组件供应商和软体公司合作，加速开发将去心房颤动与数据分析平台和电子健康记录系统连接起来的整合解决方案。

为产业领导者提供切实可行的建议，以提高去心房颤动的可及性、增强临床疗效并提高供应链的韧性。

为了最大限度地掌握当前机会并应对未来的不确定性，产业领导者应考虑一系列针对去心房颤动现状量身定制的策略挑战。采用互通性标准和开放式架构设计将加速与远端医疗平台和电子健康记录系统的集成，透过无缝资料交换和预测分析创造价值。同时，优先考虑模组化硬体架构和远端韧体更新功能将延长设备生命週期并降低最终用户的整体拥有成本。

为了获得可靠的见解，我们提出了一个详细、严谨的多来源资讯来源框架，整合了主要访谈、定量分析和二手资料检验。

本分析基于一个综合研究框架，整合了来自一手和二手调查的洞见。一手调查包括对临床心臟病专家、急救医疗服务管理人员、医疗器材工程师和采购专家的详细访谈。这些访谈提供了关于技术采纳驱动因素、工作流程整合挑战和新兴临床需求的定性观点。此外，来自监管事务顾问的见解揭示了主要司法管辖区核准标准和合规性考虑的变化。

整合有关去心房颤动发展趋势的洞察、市场动态和战略意义，以指导相关人员为未来成长做出决策。

整合对技术进步、政策影响、细微的细分市场差异以及区域趋势的洞察，揭示了去心房颤动在变革时期的现状。产品创新不断降低使用者信心和设备在所有医疗机构中整合的门槛，而监管调整和价格变化则凸显了研发和供应链策略弹性的重要性。细分市场分析强调了差异化解决方案的必要性，这些解决方案能够满足成人和儿童患者、不同医疗机构以及多种分销管道的特定需求。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章去心房颤动市场：按类型划分

  • 体外去心房颤动
    • 自动体外心臟去心房颤动
    • 手动体外电击器
    • 穿戴式去心房颤动
  • 植入式心臟整流去颤器（ICD）
    • 双腔ICD
    • 单腔植入式心律转復除颤器
    • 皮下植入式心臟復律去颤器

第九章去心房颤动市场：依技术分类

  • 两相技术
  • 单相技术

第十章去心房颤动市场：依患者类型划分

  • 成年患者
  • 儿童患者

第十一章去心房颤动市场：依最终用户划分

  • 医院
  • 院前医疗保健提供者
  • 公共和本地通道

第十二章去心房颤动市场：依供应管道划分

  • 实体店面
  • 线上平台

第十三章去心房颤动市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章去心房颤动市集：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章去心房颤动市集：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国去心房颤动市场

第十七章：中国去心房颤动市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • AMI Italia Srl
  • Avive Solutions Inc.
  • BIoTronik SE & CoKG
  • Boston Scientific Corporation
  • CU Medical Systems, Inc.
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips NV
  • Mediana Co., Ltd.
  • Medtonic PLC
  • Metsis Medikal
  • MicroPort Scientific Corporation
  • Narang Medical Limited
  • Nihon Kohden Corporation
  • OIARSO S COOP
  • Progetti Srl
  • Schiller AG
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Weinmann Emergency Medical Technology GmbH+Co. KG
  • ZOLL Medical Corporation by Asahi Kasei Corporation
Product Code: MRR-8A35583B11E2

The Defibrillators Market was valued at USD 11.86 billion in 2025 and is projected to grow to USD 12.79 billion in 2026, with a CAGR of 8.20%, reaching USD 20.61 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 11.86 billion
Estimated Year [2026] USD 12.79 billion
Forecast Year [2032] USD 20.61 billion
CAGR (%) 8.20%

A Deep Dive into the Evolution of Defibrillator Technology and Market Dynamics Shaping the Future of Sudden Cardiac Arrest Response Worldwide

The global landscape of life-saving defibrillator technology has undergone a remarkable evolution over recent decades, driven by relentless innovation and growing awareness of sudden cardiac arrest as a critical public health concern. Initially constrained to hospital environments and specialized cardiac units, modern defibrillator solutions now span wearable devices, public-access automated external defibrillators, and advanced implantable systems. This expansion reflects not only technological breakthroughs in waveform optimization and sensor integration but also a broader shift toward proactive cardiac care in both clinical and community settings.

As emergency medical services strive to reduce response times and enhance patient survival rates, the demand for portable, reliable defibrillators has surged. Simultaneously, regulatory agencies across major markets have updated standards to ensure device safety and interoperability, prompting manufacturers to refine quality controls and user-interface designs. In parallel, partnerships between medical device firms, software developers, and healthcare providers are redefining capabilities, enabling real-time remote monitoring and data analytics that inform treatment decisions.

Against this backdrop, organizations seeking to navigate the complexities of the defibrillator sector require an integrated perspective that balances clinical efficacy, regulatory compliance, and market dynamics. This executive summary delivers precisely that: a synthesis of technological trajectories, policy impacts, segmentation analyses, and regional nuances. It serves as a foundation for stakeholders to anticipate emerging trends, identify growth opportunities, and align strategic initiatives with the evolving needs of patients, healthcare systems, and first responders.

Exploring the Major Drivers and Technological Advancements That Are Redefining Defibrillator Development to Enhance Patient Outcomes in Critical Care

Defibrillator innovation today is shaped by several converging forces that collectively redefine patient care in critical moments. Advances in biphasic waveform algorithms have optimized energy delivery, reducing myocardial damage while improving conversion success rates. Meanwhile, miniaturization of electronics and battery systems has enabled the production of wearable cardioverter-defibrillators that continuously monitor cardiac rhythms and automatically deliver therapy outside hospital walls. These technological breakthroughs are complemented by the integration of connectivity features that transmit real-time patient data to clinicians, facilitating remote oversight and timely interventions.

Concurrently, regulatory landscapes in major markets have adapted to these advancements, issuing updated guidelines that emphasize device interoperability, cybersecurity safeguards, and user-friendly interfaces. As a result, manufacturers are investing in modular platforms that support software upgrades and compatibility with emerging telehealth infrastructures. Moreover, the proliferation of community-based CPR and AED training programs has spurred demand for devices designed with intuitive audiovisual prompts and simplified maintenance protocols.

The rise of value-based healthcare models further underscores the importance of outcome-driven defibrillator solutions. Providers are increasingly scrutinizing total cost of ownership, reliability metrics, and integration with electronic health records. In response, device developers are forging collaborations with healthcare IT firms to deliver comprehensive data analytics suites that track performance and inform continuous improvement initiatives. Together, these transformative shifts point toward a future where defibrillator deployment is seamlessly embedded across clinical, prehospital, and public environments, enhancing survival rates and optimizing resource utilization.

Assessing the Effects of United States Tariff Changes in 2025 on Supply Chains, Pricing Approaches, and International Cooperation in Defibrillator Delivery

The introduction of adjusted import duties by the United States in early 2025 has prompted a reevaluation of global defibrillator supply chains, cost structures, and collaborative partnerships. Manufacturers that historically relied on components sourced from Asia have begun diversifying their supplier base to mitigate tariff-induced cost increases. This strategic realignment has accelerated investment in localized manufacturing hubs, fostering closer relationships with regional contract manufacturers and promoting resilience in the event of future trade policy shifts.

As component costs escalate, original equipment manufacturers are examining pricing approaches to balance margin protection with competitive positioning. Many are negotiating long-term agreements with key suppliers to secure favorable rates, while selectively absorbing incremental expenses to preserve device affordability in critical care settings. At the same time, distributors are exploring consignment models and vendor-managed inventory programs to alleviate working capital pressures for hospitals and emergency response organizations.

Cross-border collaboration has also gained prominence as a means of sustaining innovation pipelines. Joint ventures and research alliances with European and Asia-Pacific partners are enabling shared development costs and streamlined regulatory submissions. Additionally, greater emphasis on near-shoring strategies has reduced lead times for component delivery, improving production agility and lowering logistical risks. Consequently, industry stakeholders are better equipped to navigate tariff headwinds while maintaining a robust continuum of defibrillator supply to meet growing global demand.

Uncovering Segmentation Insights That Reveal How Defibrillator Types, Technologies, Patient Groups, Usage Settings, and Distribution Modes Drive Adoption

A nuanced understanding of defibrillator market segmentation reveals the intricate interplay between device configurations, technological attributes, patient populations, care environments, and distribution pathways. When examining device classifications by type, one observes differentiation between external defibrillators-encompassing automated external defibrillators, manual external units, and wearable cardioverter systems-and implantable cardioverter-defibrillators, which span dual-chamber, single-chamber, and subcutaneous designs. These distinctions inform not only therapeutic capabilities but also regulatory requirements and clinical training protocols.

Diving deeper into technology variations, the contrast between biphasic and monophasic platforms underscores ongoing debates over efficacy, energy consumption, and manufacturing complexity. Biphasic systems, favored for their ability to achieve high conversion rates at lower energy thresholds, often command premium positioning among advanced clinical applications. Conversely, monophasic devices retain relevance in cost-sensitive contexts where simplicity and reliability are paramount.

Patient segmentation further accentuates divergent use cases, with adult patients representing the primary cohort for both external and implantable solutions, while pediatric patients drive demand for miniaturized designs and specialized waveform programming. Equally notable is the distribution of end-user settings: traditional hospital environments coexist with pre-hospital care providers such as ambulance services and first responders, alongside an expanding network of public and community access points in schools, airports, and corporate campuses.

Finally, the choice of supply channel shapes procurement lead times and service models. While offline retail remains the dominant avenue for facility-based acquisitions, online platforms are gaining traction among smaller clinics and community groups seeking convenience, expedited delivery, and transparent pricing. Together, these segmentation insights form a comprehensive tapestry that guides product development, marketing strategies, and customer engagement initiatives.

Examining Regional Characteristics That Define Defibrillator Utilization Trends across the Americas, EMEA, and Asia-Pacific Health Ecosystems

A closer examination of regional factors demonstrates how geographic distinctions influence defibrillator usage patterns, regulatory compliance, and investment priorities. In the Americas, well-established emergency medical service networks, extensive reimbursement frameworks, and high public awareness have fostered widespread deployment of automated external defibrillators in both healthcare facilities and community settings. The region's robust infrastructure enables rapid device integration alongside advanced training programs and digital connectivity solutions that facilitate remote monitoring and post-event analysis.

Within Europe, the Middle East, and Africa, diverse regulatory environments and economic conditions create a mosaic of defibrillator adoption rates. Western European nations often lead in public access initiatives, supported by harmonized safety standards and coordinated cardiovascular health campaigns. Meanwhile, burgeoning markets in the Middle East and select African countries demonstrate strong growth potential as healthcare investments surge and regulatory harmonization efforts advance. Stakeholders in these regions prioritize scalable device designs and cost-effective maintenance models to address resource constraints.

Asia-Pacific stands out for its combination of established markets and rapidly developing economies. Countries such as Japan and Australia feature mature medical device ecosystems, high per-capita device penetration, and stringent regulatory regimes that drive continuous product refinement. In contrast, emerging economies like India and Southeast Asian nations are witnessing accelerated adoption fueled by expanding healthcare infrastructure, government funding for public-access defibrillator programs, and partnerships with multinational manufacturers that bring both technological expertise and local manufacturing capacity.

Across these regional landscapes, strategic alignment with local regulatory bodies, targeted awareness campaigns, and customized service models remain critical factors for success. Recognizing the distinct priorities of each territory equips decision-makers with the insights needed to tailor product offerings and market entry strategies effectively.

Highlighting Leading Players Shaping Defibrillator Innovation through Strategic Collaborations, Technological Advances, and Clinical Research Partnerships

Industry leadership in the defibrillator sector is concentrated among a handful of companies that combine deep clinical expertise, extensive research investments, and strategic collaborations. Major medical device manufacturers leverage their global distribution networks and regulatory acumen to introduce next-generation external and implantable systems. By partnering with specialized component suppliers and software firms, these organizations accelerate the development of integrated solutions that connect defibrillators with data analytics platforms and electronic health record systems.

At the same time, emerging players carve out niches by focusing on wearable cardioverter designs and mobile-enabled automated external defibrillators. These innovators emphasize user experience, leveraging intuitive interfaces and guided resuscitation prompts to empower lay responders in high-stress scenarios. Their agility in adopting cloud-based connectivity and remote firmware management further distinguishes them within competitive portfolios.

Clinical research collaborations between device manufacturers and leading academic centers underpin ongoing efforts to validate performance across diverse patient subsets and care settings. Joint studies exploring novel waveform algorithms, adaptive energy delivery, and integrated pacing functions inform regulatory submissions and strengthen product claims. Additionally, strategic alliances with emergency medical service providers facilitate real-world trials and training initiatives that enhance user confidence.

To maintain differentiation, companies are expanding their footprints through targeted acquisitions, technology licensing agreements, and co-marketing partnerships. These directions underscore a broader trend toward ecosystem-driven innovation, where hardware, software, and service components converge to deliver seamless, outcome-focused defibrillator offerings. By tracking these strategic moves, stakeholders can identify potential collaborators, anticipate competitive pressures, and refine their own growth roadmaps.

Practical Recommendations That Industry Leaders Can Adopt to Enhance Defibrillator Accessibility, Boost Clinical Outcomes and Bolster Supply Chain Resilience

To capitalize on current opportunities and navigate future uncertainties, industry leaders should consider a series of strategic imperatives tailored to the defibrillator landscape. Embracing interoperability standards and open-architecture designs will accelerate integration with telehealth platforms and electronic health record systems, unlocking value through seamless data exchange and predictive analytics. In parallel, prioritizing modular hardware architectures and remote firmware update capabilities can extend device lifecycles and reduce total cost of ownership for end users.

Expanding community access initiatives remains a critical lever for improving survival rates and driving device adoption. By collaborating with public health organizations, private institutions, and first responder networks, device manufacturers can deploy training-embedded defibrillator programs that foster confidence among lay users. Furthermore, leveraging mobile applications and cloud-based registries enhances transparency around device locations and performance metrics, enabling faster intervention in emergencies.

Building supply chain resilience through diversified sourcing strategies and near-shoring partnerships will mitigate exposure to geopolitical disruptions and tariff fluctuations. Coupled with flexible production models and just-in-time inventory approaches, these measures can sustain timely device delivery while preserving margins. Equally important is investing in service-oriented business models-such as outcome-based service contracts-that align manufacturer incentives with patient and provider needs.

Finally, engaging proactively with regulatory bodies and standards organizations will reduce approval timelines for breakthrough innovations. Establishing evidence-driven pathways for novel waveform algorithms, wearable defibrillator systems, and AI-assisted monitoring tools can secure competitive advantage. By implementing these recommendations, industry leaders will strengthen their market positions and accelerate progress toward more accessible, effective, and integrated defibrillator solutions.

Detailing a Rigorous Multi-Source Research Framework Integrating Primary Interviews, Quantitative Analysis, and Secondary Data Validation for Robust Insights

This analysis is grounded in a comprehensive research framework that integrates insights from primary and secondary sources. Primary research efforts included in-depth interviews with clinical cardiologists, emergency medical service directors, device engineers, and procurement specialists. These discussions provided qualitative perspectives on technology adoption drivers, workflow integration challenges, and emerging clinical requirements. Additionally, insights from regulatory affairs consultants elucidated evolving approval criteria and compliance considerations across key jurisdictions.

Secondary research incorporated a thorough review of publicly available regulatory filings, clinical trial registries, industry white papers, and peer-reviewed publications. This phase of the study enabled cross-validation of technological trends, safety performance data, and device utilization patterns. Market intelligence databases were also consulted to map recent partnerships, product launches, and research initiatives.

Quantitative analysis involved synthesizing aggregate device shipment figures, reimbursement framework comparisons, and healthcare infrastructure metrics to contextualize adoption benchmarks. Data triangulation methods were employed to reconcile variations across sources and ensure robustness. Quality assurance protocols included peer review by domain experts and consistency checks against clinical outcome registries.

The resulting methodology delivers a balanced, evidence-based perspective that captures both macro-level market forces and micro-level clinical nuances. By adhering to rigorous standards of data validation and leveraging multi-stakeholder feedback loops, this report provides stakeholders with a high degree of confidence in its strategic insights and recommendations.

Bringing Together Defibrillator Evolution Insights, Market Dynamics, and Strategic Implications to Guide Stakeholder Decision-Making for Future Growth

Bringing together insights on technological evolution, policy influences, segmentation nuances, and regional dynamics reveals a defibrillator landscape in transition. Product innovation continues to lower barriers to user confidence and device integration across care environments, while regulatory adaptations and tariff shifts underscore the importance of agility in both development and supply chain strategies. Segmentation analyses highlight the need for differentiated solutions that address the specific requirements of adult and pediatric patients, various healthcare settings, and multiple distribution pathways.

Regional perspectives accentuate how established markets leverage mature infrastructures, while emerging economies present fertile ground for strategic partnerships and tailored deployment models. Industry leaders are responding with collaborations that span clinical research, digital health integration, and cross-border manufacturing alliances. These collective efforts underscore a broader movement toward ecosystem-driven defibrillator solutions that combine hardware, software, and service components in pursuit of improved patient outcomes and operational efficiency.

The actionable recommendations outlined herein provide a roadmap for enhancing device interoperability, strengthening community access programs, fortifying supply chains, and expediting regulatory approvals. By aligning product roadmaps with evolving clinical needs and embracing flexible business models, stakeholders can navigate market complexities and capture growth opportunities.

Ultimately, this synthesis equips decision-makers with the clarity and foresight necessary to drive the next wave of advancements in defibrillator therapy, ensuring that lifesaving interventions become ever more accessible, effective, and integrated within global healthcare systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Defibrillators Market, by Type

  • 8.1. External Defibrillators
    • 8.1.1. Automated External Defibrillators (AED)
    • 8.1.2. Manual External Defibrillators
    • 8.1.3. Wearable Cardioverter Defibrillators
  • 8.2. Implantable Cardioverter Defibrillators (ICD)
    • 8.2.1. Dual-Chamber ICDs
    • 8.2.2. Single-Chamber ICDs
    • 8.2.3. Subcutaneous ICDs

9. Defibrillators Market, by Technology

  • 9.1. Biphasic Technology
  • 9.2. Monophasic Technology

10. Defibrillators Market, by Patient Type

  • 10.1. Adult Patients
  • 10.2. Pediatric Patients

11. Defibrillators Market, by End User

  • 11.1. Hospitals
  • 11.2. Pre-Hospital Care Providers
  • 11.3. Public & Community Access

12. Defibrillators Market, by Supply Channel

  • 12.1. Offline Retails
  • 12.2. Online Platforms

13. Defibrillators Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Defibrillators Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Defibrillators Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Defibrillators Market

17. China Defibrillators Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. AMI Italia S.r.l.
  • 18.7. Avive Solutions Inc.
  • 18.8. Biotronik SE & CoKG
  • 18.9. Boston Scientific Corporation
  • 18.10. CU Medical Systems, Inc.
  • 18.11. GE HealthCare Technologies Inc.
  • 18.12. Koninklijke Philips N.V.
  • 18.13. Mediana Co., Ltd.
  • 18.14. Medtonic PLC
  • 18.15. Metsis Medikal
  • 18.16. MicroPort Scientific Corporation
  • 18.17. Narang Medical Limited
  • 18.18. Nihon Kohden Corporation
  • 18.19. OIARSO S COOP
  • 18.20. Progetti Srl
  • 18.21. Schiller AG
  • 18.22. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 18.23. Stryker Corporation
  • 18.24. Thermo Fisher Scientific Inc.
  • 18.25. Weinmann Emergency Medical Technology GmbH + Co. KG
  • 18.26. ZOLL Medical Corporation by Asahi Kasei Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL DEFIBRILLATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DEFIBRILLATORS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DEFIBRILLATORS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DEFIBRILLATORS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DEFIBRILLATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DEFIBRILLATORS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DEFIBRILLATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DEFIBRILLATORS MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS (AED), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DEFIBRILLATORS MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS (AED), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DEFIBRILLATORS MARKET SIZE, BY AUTOMATED EXTERNAL DEFIBRILLATORS (AED), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DEFIBRILLATORS MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DEFIBRILLATORS MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DEFIBRILLATORS MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DEFIBRILLATORS MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DEFIBRILLATORS MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DEFIBRILLATORS MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DEFIBRILLATORS MARKET SIZE, BY DUAL-CHAMBER ICDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DEFIBRILLATORS MARKET SIZE, BY DUAL-CHAMBER ICDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DEFIBRILLATORS MARKET SIZE, BY DUAL-CHAMBER ICDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DEFIBRILLATORS MARKET SIZE, BY SINGLE-CHAMBER ICDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DEFIBRILLATORS MARKET SIZE, BY SINGLE-CHAMBER ICDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DEFIBRILLATORS MARKET SIZE, BY SINGLE-CHAMBER ICDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS ICDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS ICDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS ICDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DEFIBRILLATORS MARKET SIZE, BY BIPHASIC TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DEFIBRILLATORS MARKET SIZE, BY BIPHASIC TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DEFIBRILLATORS MARKET SIZE, BY BIPHASIC TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DEFIBRILLATORS MARKET SIZE, BY MONOPHASIC TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DEFIBRILLATORS MARKET SIZE, BY MONOPHASIC TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DEFIBRILLATORS MARKET SIZE, BY MONOPHASIC TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DEFIBRILLATORS MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DEFIBRILLATORS MARKET SIZE, BY ADULT PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DEFIBRILLATORS MARKET SIZE, BY ADULT PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PEDIATRIC PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PEDIATRIC PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DEFIBRILLATORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PRE-HOSPITAL CARE PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PRE-HOSPITAL CARE PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PRE-HOSPITAL CARE PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PUBLIC & COMMUNITY ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PUBLIC & COMMUNITY ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DEFIBRILLATORS MARKET SIZE, BY PUBLIC & COMMUNITY ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DEFIBRILLATORS MARKET SIZE, BY OFFLINE RETAILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DEFIBRILLATORS MARKET SIZE, BY OFFLINE RETAILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DEFIBRILLATORS MARKET SIZE, BY OFFLINE RETAILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DEFIBRILLATORS MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DEFIBRILLATORS MARKET SIZE, BY ONLINE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DEFIBRILLATORS MARKET SIZE, BY ONLINE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DEFIBRILLATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS DEFIBRILLATORS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL DEFIBRILLATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. GCC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GCC DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. GCC DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 137. GCC DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 138. GCC DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. GCC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. GCC DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. GCC DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 154. BRICS DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. G7 DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. G7 DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 161. G7 DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 162. G7 DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. G7 DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. G7 DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. G7 DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. NATO DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. NATO DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 169. NATO DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 170. NATO DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. NATO DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. NATO DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. NATO DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES DEFIBRILLATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA DEFIBRILLATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA DEFIBRILLATORS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA DEFIBRILLATORS MARKET SIZE, BY EXTERNAL DEFIBRILLATORS, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICD), 2018-2032 (USD MILLION)
  • TABLE 187. CHINA DEFIBRILLATORS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA DEFIBRILLATORS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA DEFIBRILLATORS MARKET SIZE, BY SUPPLY CHANNEL, 2018-2032 (USD MILLION)